| 12486290 |
Isoindolinone and indazole compounds for the degradation of EGFR |
Christopher G. Nasveschuk, Martin Duplessis, Jae Yeon AHN, Alexander Hird, Ryan E. Michael +5 more |
2025-12-02 |
|
| 12479849 |
EGFR inhibitors for the treatment of cancer |
Cosimo Dolente, David Stephen Hewings, Georg Jaeschke, Bernd Kuhn, Yvonne Alice Nagel +4 more |
2025-11-25 |
|
| 12371442 |
Isoindolinone and indazole compounds for the degradation of EGFR |
Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Alexander Hird, Ryan E. Michael +5 more |
2025-07-29 |
|
| 12365681 |
Dihydrobenzimidazolones for medical treatment |
Roger Norcross, Fabian Dey, Eric Andre Kusznir |
2025-07-22 |
|
| 12344613 |
EGFR inhibitor for the treatment of cancer |
Cosimo Dolente, David Stephen Hewings, Georg Jaeschke, Bernd Kuhn, Yvonne Alice Nagel +4 more |
2025-07-01 |
|
| 12227504 |
Spirocyclic compounds |
Christopher G. Nasveschuk, Fabian Dey, Bernd Kuhn, Roger Norcross, Stephan Roever +1 more |
2025-02-18 |
|
| 12209091 |
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers |
Martin Duplessis, Georg Jaeschke, Buelent Kocer, Bernd Kuhn, Kiel Lazarski +6 more |
2025-01-28 |
|
| 12091397 |
Dihydroquinolinones for medical treatment |
Roger Norcross, Adrian Britschgi, Fabian Dey, Eric Andre Kusznir, Moreno Attilio Wichert |
2024-09-17 |
$20,283,000 |
| 11802131 |
Glutarimides for medical treatment |
Roger Norcross, Philipp Schmid, Fabian Dey, Eric Andre Kusznir |
2023-10-31 |
$1,253,000 |
| 11787802 |
Dihydrobenzimidazolones for medical treatment |
Roger Norcross, Fabian Dey, Eric Andre Kusznir |
2023-10-17 |
$1,657,000 |
| 11673902 |
Isoindolinone and indazole compounds for the degradation of EGFR |
Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Alexander Hird, Ryan E. Michael +5 more |
2023-06-13 |
$2,984,000 |
| 11623929 |
Spirocyclic compounds |
Christopher G. Nasveschuk, Fabian Dey, Roger Norcross, Philipp Schmid |
2023-04-11 |
$3,008,000 |
| 11584748 |
Spirocyclic compounds |
Christopher G. Nasveschuk, Fabian Dey, Bernd Kuhn, Roger Norcross, Stephan Roever +1 more |
2023-02-21 |
$6,868,000 |
| 11401256 |
Dihydroquinolinones for medical treatment |
Roger Norcross, Adrian Britschgi, Fabian Dey, Eric Andre Kusznir, Moreno Attilio Wichert |
2022-08-02 |
$11,043,000 |
| 11319314 |
Phenoxytriazoles |
Bjoern Bartels, Stefan BERCHTOLD, Guido Galley, Roland Jakob-Roetne, Daniela Krummenacher +6 more |
2022-05-03 |
|
| 11254672 |
Dihydrobenzimidazolones for medical treatment |
Roger Norcross, Fabian Dey, Eric Andre Kusznir |
2022-02-22 |
$15,249,000 |
| 9957261 |
6-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives |
Giuseppe Cecere, Guido Galley, Roger Norcross, Philippe Pflieger, Alina Tirla +1 more |
2018-05-01 |
|
| 9181230 |
Morpholine compounds and uses thereof |
Guido Galley, Roger Norcross, Philippe Pflieger |
2015-11-10 |
|
| 8729113 |
4,5-dihydro-oxazol-2yl derivatives |
Guido Galley, Katrin Groebke Zbinden, Roger Norcross |
2014-05-20 |
|
| 8586617 |
Aminomethyl-4-imidazoles |
Guido Galley, Katrin Groebke Zbinden, Roger Norcross, Henri Stalder |
2013-11-19 |
|
| 8389507 |
2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands |
Guido Galley, Katrin Groebke Zbinden, Roger Norcross, Henri Stalder |
2013-03-05 |
|
| 8242153 |
4,5-dihydro-oxazol-2YL derivatives |
Guido Galley, Katrin Groebke Zbinden, Roger Norcross |
2012-08-14 |
|
| 7375099 |
Malonamide derivatives |
Guido Galley, Helmut Jacobsen, Eric A. Kitas, Jens-Uwe Peters |
2008-05-20 |
|
| 6482829 |
Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor |
Guido Galley, Thierry Godel, Torsten Hoffmann, Sabine Kolczewski, Stephan Roever |
2002-11-19 |
|
| 6452001 |
Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation |
Guido Galley, Thierry Godel, Reinhard Heck |
2002-09-17 |
|
